Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma. Shi, W., Kleinberg, L., Jeyapalan, S. A., Goldlust, S. A., Nagpal, S., Combs, S. E., Roberge, D., Nishigawa, R., Grossman, R., Glas, M. AMER ASSOC CANCER RESEARCH. 2021
View details for Web of Science ID 000680263501370